z-logo
Premium
Preparation of tritium‐labeled PF‐622, a novel fatty acid amide hydrolase inhibitor
Author(s) -
Zhang Yinsheng
Publication year - 2017
Publication title -
journal of labelled compounds and radiopharmaceuticals
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.432
H-Index - 47
eISSN - 1099-1344
pISSN - 0362-4803
DOI - 10.1002/jlcr.3559
Subject(s) - chemistry , moiety , piperazine , tritium , amide , catalysis , fatty acid amide hydrolase , ring (chemistry) , isotopomers , stereochemistry , selectivity , bromide , fatty acid , organic chemistry , biochemistry , physics , receptor , cannabinoid receptor , molecule , nuclear physics , agonist
To make a detailed characterization of the mechanism of inhibition and selectivity of a novel fatty acid amide hydrolase inhibitor PF‐622 , 3 tritium isotopomers were prepared. [ 3 H] PF‐622a labeled at the piperazine ring B and [ 3 H] PF‐622b labeled at both the ring B and phenyl ring A were synthesized via catalytic H(hydrogen)‐T(tritium) exchange, utilizing 1 equiv and excess of Crabtree's catalyst, respectively. The preparation of [ 3 H] PF‐622c labeled only at the phenyl ring A was achieved via tritiodebromination of the bromide precursor, using Pd(PPh 3 ) 4 as a catalyst. The observations from these tritiation reactions might open a new perspective in the labeling for the targets having a similar moiety.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom